...
首页> 外文期刊>Surgery >Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.
【24h】

Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989.

机译:从1940年至1989年在一家机构中治疗的300例病理性肿瘤-淋巴结转移性III期乳头状甲状腺癌患者中,初次手术对结局的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The pathologic tumor-node-metastasis (pTNM) system is universally used to define the extent of disease in human malignancies. This study evaluated the impact of initial therapy on cause-specific mortality (CSM) rates and recurrence rates in pTNM stage III papillary thyroid carcinoma. METHODS: Three hundred patients (median age, 58 years) were followed on average for 14 postoperative years. Of these, 246 patients (82%) had complete primary tumor resection; 208 patients (69%) had nodal metastases; 161 (54%) had locally invasive primary tumors; 45 patients (15%) underwent initial unilateral lobectomy (UL). Bilateral lobar resection (BLR) accounted for 242 patients (near-total, 54%; total thyroidectomy, 23%). RESULTS: The 30-year rates for CSM, distant metastases, nodal metastases, and local recurrence (LR) were 29%, 22%, 19%, and 16%, respectively. The 20-year rates for CSM were significantly higher (50% vs 14%) when primary tumor was incompletely resected (P = .0001). After complete resection, 20-year rates for CSM and LR after BLR were 12% and 10%, respectively, which were significantly lower (P < .05) than the 23% and 26% rates seen after UL. There were no significant differences in nodal metastases or distant metastases rates between UL and BLR (P > .4). The 20-year LR rate after total thyroidectomy (13%) was not different (P = .5) from the 11% seen after near-total thyroidectomy. CONCLUSIONS: In this nonrandomized evaluation of patients with pTNM stage III papillary thyroid carcinoma, the extent of primary thyroid resection appeared to significantly impact CSM and LR but did not apparently influence regional or distant metastasis.
机译:背景:病理性肿瘤-淋巴结转移(pTNM)系统普遍用于定义人类恶性肿瘤的疾病范围。这项研究评估了初始治疗对pTNM III期甲状腺乳头状癌的病因死亡率(CSM)率和复发率的影响。方法:平均随访300例患者(中位年龄58岁),术后14年。其中246例(82%)患者已完成原发肿瘤切除; 208例(69%)有淋巴结转移; 161例(54%)患有局部浸润性原发肿瘤; 45例患者(占15%)接受了初始单侧肺叶切除术(UL)。双侧大叶切除术(BLR)占242例(占总数的54%;全甲状腺切除术占23%)。结果:CSM,远处转移,淋巴结转移和局部复发(LR)的30年发生率分别为29%,22%,19%和16%。当原发肿瘤未完全切除时,CSM的20年发病率显着更高(50%比14%)(P = .0001)。完全切除后,BLR后CSM和LR的20年发生率分别为12%和10%,这显着低于(P <.05)UL发生后的23%和26%。 UL和BLR之间的淋巴结转移或远处转移率无显着差异(P> .4)。全甲状腺切除术后20年LR率(13%)与近全甲状腺切除术后11%的观察率无差异(P = 0.5)。结论:在对pTNM III期甲状腺乳头状癌患者的非随机评估中,原发性甲状腺切除的程度似乎对CSM和LR有显着影响,但对区域或远处转移没有明显影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号